These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26453528)

  • 1. Anemia and its association with clinical outcome in heart failure patients undergoing cardiac resynchronization therapy.
    Venkateswaran RV; Freeman C; Chatterjee N; Kandala J; Orencole M; Vegh EM; Parks KA; Cowburn PJ; Dec GW; Singh JP; Borgquist R
    J Interv Card Electrophysiol; 2015 Dec; 44(3):297-304. PubMed ID: 26453528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Left Ventricular Remodeling and Regional Dyssynchrony on Long-Term Prognosis after Cardiac Resynchronization Therapy.
    Tayal B; Sogaard P; Delgado-Montero A; Goda A; Saba S; Risum N; Gorcsan J
    J Am Soc Echocardiogr; 2017 Mar; 30(3):244-250. PubMed ID: 27986357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy.
    Singal G; Upadhyay GA; Borgquist R; Friedman DJ; Chatterjee NA; Kandala J; Park MY; Orencole M; Dec GW; Picard MH; Singh JP; Mela T
    Pacing Clin Electrophysiol; 2015 Oct; 38(10):1192-200. PubMed ID: 26179289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure.
    Peterson PN; Magid DJ; Lyons EE; Clarke CL; Zeng C; Fitzgerald A; Lindenfeld J; Kosiborod M; Brand D; Masoudi FA
    Am Heart J; 2010 Jan; 159(1):81-9. PubMed ID: 20102871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of hyponatremia as a predictor for adverse events in patients with heart failure receiving cardiac resynchronization therapy.
    Sharma AK; Vegh EM; Kandala J; Orencole M; Januszkiewicz L; Bose A; Miller A; Parks KA; Heist EK; Singh JP
    Am J Cardiol; 2014 Jul; 114(1):83-7. PubMed ID: 24852916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female gender is associated with a better outcome after cardiac resynchronization therapy.
    Leyva F; Foley PW; Chalil S; Irwin N; Smith RE
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):82-8. PubMed ID: 21214589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.
    Trucco E; Tolosana JM; Castel MÁ; Batlle M; Borràs R; Sitges M; Guash E; Matas M; Arbelo E; Berruezo A; Brugada J; Mont L
    Europace; 2016 Feb; 18(2):232-7. PubMed ID: 25883077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of baseline big endothelin-1 level with long-term prognosis among cardiac resynchronization therapy recipients.
    Yang S; Liu Z; Liu S; Ding L; Chen K; Hua W; Zhang S
    Clin Biochem; 2018 Sep; 59():25-30. PubMed ID: 29913121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
    J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure and anemia: Effects on prognostic variables.
    Cattadori G; Agostoni P; Corrà U; Sinagra G; Veglia F; Salvioni E; Bonomi A; La Gioia R; Scardovi AB; Ferraironi A; Emdin M; Metra M; Di Lenarda A; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Caravita S; Magrì D; Lombardi C; Frigerio M; Oliva F; Girola D; Mezzani A; Farina S; Mapelli M; Scrutinio D; Pacileo G; Apostolo A; Iorio A; Paolillo S; Filardi PP; Gargiulo P; Bussotti M; Marchese G; Correale M; Badagliacca R; Sciomer S; Palermo P; Contini M; Giannuzzi P; Battaia E; Cicoira M; Clemenza F; Minà C; Binno S; Passino C; Piepoli MF;
    Eur J Intern Med; 2017 Jan; 37():56-63. PubMed ID: 27692931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Ventricular Size does not Modify the Effect of QRS Duration in Predicting Response to Cardiac Resynchronization Therapy.
    Rickard J; Baranowski B; Grimm RA; Niebauer M; Varma N; Tang WHW; Wilkoff BL
    Pacing Clin Electrophysiol; 2017 May; 40(5):482-487. PubMed ID: 28164328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Relative Hypochromia in Risk Stratification for Nonanemic Patients With Chronic Heart Failure.
    Hammadah M; Brennan ML; Wu Y; Hazen SL; Tang WH
    Am J Cardiol; 2016 Apr; 117(8):1299-304. PubMed ID: 26897638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and Clinical Outcomes of Transient Responders to Cardiac Resynchronization Therapy.
    Ichibori H; Fukuzawa K; Kiuchi K; Matsumoto A; Konishi H; Imada H; Hyogo K; Kurose J; Tatsumi K; Tanaka H; Hirata KI
    Pacing Clin Electrophysiol; 2017 Mar; 40(3):301-309. PubMed ID: 28083969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrical remodeling reflected by QRS and T vector changes following cardiac resynchronization therapy is related to survival in heart failure patients with left bundle branch block.
    Floré V; Bartunek J; Goethals M; Verstreken S; Timmermans W; De Pauw F; Van Bockstal K; Vanderheyden M
    J Electrocardiol; 2015; 48(4):578-85. PubMed ID: 25747167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Iron Deficiency on Response to and Remodeling After Cardiac Resynchronization Therapy.
    Martens P; Verbrugge F; Nijst P; Dupont M; Tang WH; Mullens W
    Am J Cardiol; 2017 Jan; 119(1):65-70. PubMed ID: 27780556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia in chronic heart failure patients: comparison between invasive and non-invasive prognostic markers.
    Ceresa M; Capomolla S; Pinna G; Aiolfi E; La Rovere MT; Febo O; Paganini V; Rossi A; Guazzotti G; Caporotondi A; Maestri R; Cobelli F
    Monaldi Arch Chest Dis; 2005 Jun; 64(2):124-33. PubMed ID: 16499298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: results of the Japanese heart failure syndrome with preserved ejection fraction registry.
    Okuno K; Naito Y; Asakura M; Sugahara M; Ando T; Yasumura S; Nagai T; Saito Y; Yoshikawa T; Masuyama T; Anzai T
    Heart Vessels; 2019 Jul; 34(7):1168-1177. PubMed ID: 30675647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.